Gene therapy for female infertility: A farfetched dream or reality?

Pathak, Subhajit; Sarangi, Pratiksha; Jayandharan, Giridhara R.

doi:10.1016/j.xcrm.2022.100641

Cell Reports Medicine

2022

DOI: 10.1016/j.xcrm.2022.100641

|View full text |Cite

Gene therapy for female infertility: A farfetched dream or reality?

Subhajit Pathak

Pratiksha Sarangi

Giridhara R. Jayandharan

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2023

Publication Types

Select...

Article1

Relationship

Self Cite0

Independent1

Authors

Journals

Cited by 1 publication

References 10 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

Nanomedicine for Maternal and Fetal Health

Carter,

Better,

Abbasi

et al. 2023

Small

View full text Add to dashboard Cite

Conception, pregnancy, and childbirth are complex processes that affect both mother and fetus. Thus, it is perhaps not surprising that in the United States alone, roughly 11% of women struggle with infertility and 16% of pregnancies involve some sort of complication. This presents a clear need to develop safe and effective treatment options, though the development of therapeutics for use in women's health and particularly in pregnancy is relatively limited. Physiological and biological changes during the menstrual cycle and pregnancy impact biodistribution, pharmacokinetics, and efficacy, further complicating the process of administration and delivery of therapeutics. In addition to the complex pharmacodynamics, there is also the challenge of overcoming physiological barriers that impact various routes of local and systemic administration, including the blood–follicle barrier and the placenta. Nanomedicine presents a unique opportunity to target and sustain drug delivery to the reproductive tract and other relevant organs in the mother and fetus, as well as improve the safety profile and minimize side effects. Nanomedicine‐based approaches have the potential to improve the management and treatment of infertility, obstetric complications, and fetal conditions.

show abstract

Nanomedicine for Maternal and Fetal Health

Carter,

Better,

Abbasi

et al. 2023

Small

View full text Add to dashboard Cite

show abstract

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

customersupport@researchsolutions.com

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Gene therapy for female infertility: A farfetched dream or reality?

Cited by 1 publication

References 10 publications

Nanomedicine for Maternal and Fetal Health

Nanomedicine for Maternal and Fetal Health

Contact Info

Product

Resources

About